Coramaze Technologies
Last verified 2026-05-19. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $6.5Mattributed |
|---|---|
| Latest round | grant, $2.7M, 2026-02-01attributed |
| Founded | 2013 |
| Headquarters | Petah Tikva, Israel |
| Industry | healthtech |
| Stage | unknown |
| Website | tripairtechnology.com |
Coramaze develops Tripair, a minimally invasive transcatheter system to repair the tricuspid valve in patients with tricuspid regurgitation. It targets the many patients with severe tricuspid regurgitation who go untreated because existing therapies are too complex. It is designed to be as simple as a right-heart catheterization so any interventionalist can perform it, spun out of the University of Essen.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-02-01 | grant | $2.7M | undisclosed |
Detected tech stack
LiteSpeed, PHP 8.3.31, WordPress, AitThemes, Lenis 1.1.13, Yoast SEO 26.3, WP Rocket 3.20.0.3, MySQL
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Total raised $6.5M | attributed | eu-grant named as publisher. No document URL on file. |
| Company existence | self-reported | tripairtechnology.com, read 2026-05-19 |
| Description | self-reported | tripairtechnology.com, read 2026-05-19 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.